Institutional-level securities research, however, is generally out of reach for the small investor. The cost of such research is simply prohibitive. So how can a retail investor get access to ...

IGM Biosciences (IGMS – Research Report) received a Sell rating and a $0.75 price target from Bank of America Securities analyst Charlie CY ...

Our research team assigns Silver ratings to strategies ... Dimensional Fund Advisors treats real estate securities differently than it does other stocks. The firm normally favors companies with ...